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Clonal complex 5 methicillin-resistant Staphylococcus aureus (CC5-MRSA) includes
multiple prevalent clones that cause hospital-associated infections in the Western
Hemisphere. Here, we present a phylogenomic study of these MRSA to reveal their
phylogeny, spatial and temporal population structure, and the evolution of selected
traits. We studied 598 genome sequences, including 409 newly generated sequences,
from 11 countries in Central, North, and South America, and references from Asia
and Europe. An early-branching CC5-Basal clade is well-dispersed geographically, is
methicillin-susceptible and MRSA predominantly of ST5-IV such as the USA800 clone,
and includes separate subclades for avian and porcine strains. In the early 1970s and
early 1960s, respectively, two clades appeared that subsequently underwent major
expansions in the Western Hemisphere: a CC5-I clade in South America and a CC5-
II clade largely in Central and North America. The CC5-I clade includes the ST5-I
Chilean/Cordobes clone, and the ST228-I South German clone as an early offshoot,
but is distinct from other ST5-I clones from Europe that nest within CC5-Basal. The
CC5-II clade includes divergent strains of the ST5-II USA100 clone, various other
clones, and most known vancomycin-resistant strains of S. aureus, but is distinct
from ST5-II strain N315 from Japan that nests within CC5-Basal. The recombination
rate of CC5 was much lower than has been reported for other S. aureus genetic
backgrounds, which indicates that recurrence of vancomycin resistance in CC5 is not
likely due to an enhanced promiscuity. An increased number of antibiotic resistances
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and decreased number of toxins with distance from the CC5 tree root were observed.
Of note, the expansions of the CC5-I and CC5-II clades in the Western Hemisphere
were preceded by convergent gains of resistance to fluoroquinolone, macrolide, and
lincosamide antibiotics, and convergent losses of the staphylococcal enterotoxin p (sep)
gene from the immune evasion gene cluster of phage φSa3. Unique losses of surface
proteins were also noted for these two clades. In summary, our study has determined
the relationships of different clades and clones of CC5 and has revealed genomic
changes for increased antibiotic resistance and decreased virulence associated with
the expansions of these MRSA in the Western Hemisphere.
Keywords: methicillin-resistant Staphylococcus aureus, MRSA, phylogenomics, convergent evolution, local
adaptation
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) is among
the leading causes of antibiotic-resistant bacterial infections
in hospital and community settings (Centers for Disease
Control and Prevention, 2013; World Health Organization,
2014). These infections can range in severity from superficial
skin infections to life-threatening invasive infections such
as sepsis, infective endocarditis, and osteomyelitis (Boucher
et al., 2010). Different MRSA clones predominate in different
geographic regions and can differ in the rates and types of
infections that they cause (Grundmann et al., 2010; David
et al., 2014). Over the past 20 years, MRSA related to
multilocus sequence type (ST) 5, which is classified into
clonal complex (CC) 5, have been among the most prevalent
clones causing hospital-associated infections in the Western
Hemisphere (Aires De Sousa et al., 2001; Christianson et al.,
2007; Rodriguez-Noriega et al., 2010; Diekema et al., 2014;
Arias et al., 2017; Tickler et al., 2017). CC5-MRSA clones
can differ in their Staphylococcal Chromosomal Cassette
mec (SCCmec) genetic element, which carries the resistance
determinant to anti-staphylococcal β-lactams, and in gene
content (Christianson et al., 2007; Monecke et al., 2011). The
identification of MRSA clones based on ST-SCCmec types
(Robinson and Enright, 2004) has allowed for more precise
transnational communication and tracking of these clones, and
characterization of gene content has provided additional markers
and insights into the lifestyles of these clones (Monecke et al.,
2011).
Studies have identified the ST5-I Chilean/Cordobes
clone (Sola et al., 2002), the ST5-II Canadian MRSA-2,
New York/Japan, and USA100 clones (Roberts et al., 1998;
McDougal et al., 2003; Christianson et al., 2007), and the
ST5-IV USA800 clone (McDougal et al., 2003), as particularly
common in the Western Hemisphere. For example, in the
United States, ST5-II may have accounted for >40% of MRSA
infections since the mid-1990s (Roberts et al., 1998; McDougal
et al., 2003). In the southern cone of South America, ST5-I
may have accounted for >60% of MRSA infections since the
early 2000s (Sola et al., 2006). More recently in this region
of South America, ST5-IV with pvl and sea toxin genes have
emerged as a cause of community-associated infections and
hospital infections especially among children (Sola et al., 2008;
Egea et al., 2014). Other CC5-MRSA clones with SCCmec
types I–VII have been reported elsewhere in the world
(Monecke et al., 2011). In some cases, such as the ST225-II
Rhine-Hesse clone in Central Europe (Nubel et al., 2010)
and ST5-II in Western Australia (Coombs et al., 2007), the
Western Hemisphere has been implicated as the origin of the
clones.
Importantly, CC5 is the principal genetic background within
S. aureus upon which full resistance to vancomycin—one of
the drugs of choice for treating MRSA infections—repeatedly
has arisen by acquisition of the vanA operon from Enterococcus
spp. (Kos et al., 2012). The reasons why CC5 and not
other S. aureus backgrounds has been the focal point for
these acquisitions are not clear, but could include increased
promiscuity, a genome that is conducive to vanA expression,
or a shared niche with Enterococcus spp. In addition to the
substantial disease caused by CC5-MRSA in human populations,
the CC5 background has adapted to bird species and become
a source of infection among broiler poultry (Lowder et al.,
2009). The CC5 background also has been isolated from
pigs (Frana et al., 2013), and with some traits that are
present in other pig-adapted MRSA backgrounds (Hau et al.,
2015).
The phylogenetic relationships between the numerous
CC5-MRSA clones have not been determined, nor have
the evolutionary events that led to their emergence. CC8
is the rival of CC5 for prominence among MRSA in the
Western Hemisphere, and CC8-MRSA clone relationships
and evolution have been studied extensively through
genome sequencing (Uhlemann et al., 2014; Alam et al.,
2015; Planet et al., 2015; Glaser et al., 2016; Challagundla
et al., 2018). Relatively small samples of CC5-MRSA
have been similarly studied (Kos et al., 2012; Aanensen
et al., 2016; Arias et al., 2017). Here, we provide the first
phylogenomic study of CC5-MRSA that is focused on large
samples from the Western Hemisphere. Our goals are to
resolve the phylogeny, place and time of origin of major
CC5-MRSA clones, and to trace the evolution of their key
traits.
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MATERIALS AND METHODS
Bacterial Samples and Genome
Sequencing
The genome sequences of 598 strains of CC5 were studied here.
Sequences were newly generated for 409 strains, and published
sequences were downloaded from publicly available sources for
189 strains. The newly generated sequences were from three
sequencing facilities: the Broad Institute (n = 297), the University
of Mississippi Medical Center (UMMC, n = 74), and Universidad
El Bosque (UEB, n = 38). Information on these sequences is
provided in Supplementary Table S1. All new sequences were
generated using Illumina instruments. The Broad Institute’s
sequencing procedures are described in Supplementary Text S1,
whereas previously published procedures were used at UMMC
(Challagundla et al., 2018) and UEB (Arias et al., 2017).
Eleven countries in the Western Hemisphere were sampled:
Argentina, n = 30; Brazil, n = 23; Canada, n = 36; Chile,
n = 23; Colombia, n = 56; Ecuador, n = 9; Guatemala,
n = 21; Mexico, n = 40; Peru, n = 28; United States,
n = 270; and Venezuela, n = 21. The US samples consisted
of separate large collections: California, n = 40; Massachusetts,
n = 40; Mississippi, n = 89; New York, n = 74; plus reference
strains of USA100 and USA800, vancomycin-resistant S. aureus
(VRSA), and avian and porcine strains. Other strains included
completely sequenced reference strains JH1, N315, ED98, CF-
Marseille, and 32 strains from Europe. Dates of isolation
ranged from 1964 to 2017. Most strains were from clinical
specimens.
Genome Assembly, Pseudoread
Generation, and Alignment
Some of the published sequences were available only
as assembled genomes. For those published sequences
available as reads, and for the new sequences generated
by UMMC, assemblies were made after filtering reads
for minimum quality (base quality ≥ Q13, number of
ambiguities ≤ 2, read length ≥ 15) using CLC Genomics
Workbench v7 (Qiagen, Aarhus, Denmark). For those new
sequences generated by the Broad Institute, assembly was
carried out using the ALLPATHS-LG pipeline1, followed
by automated assembly improvement using Pilon2. Quality
measures of all assemblies are listed in Supplementary
Table S1.
In order to align this heterogeneous sample of sequences,
we first used wgsim v0.3.2 (Li et al., 2009) with each assembly
to generate 500,000 paired-end pseudoreads of 100 bp, with
a 200 bp distance between the ends. These pseudoreads were
mapped to the complete reference sequence of CC5 strain JH1
(Mwangi et al., 2007) using bwa v0.7.12 (Li and Durbin, 2010),
coordinate-sorted with Picard v1.141 (DePristo et al., 2011),
and realigned around indels with GATK v2.8-1 (DePristo et al.,
2011).
1http://www.broadinstitute.org/software/allpaths-lg/blog
2http://www.broadinstitute.org/software/pilon/
Variant Calling and Functional Effects
Single-nucleotide polymorphisms (SNPs) and short insertion–
deletion polymorphisms (indels) were called with the
UnifiedGenotyper walker of GATK. All self-similar sequences
identified by pairwise megablast of the CC5 reference sequence
against itself, plus five regions of mobile genetic elements, were
excluded from variant calling. Mapping quality was >50 for all
variants. The functional effects of the variants were determined
using SnpEff v4 (Cingolani et al., 2012) with the annotation of
the CC5 reference sequence.
Strain Typing and Prediction of Antibiotic
Resistance
Multilocus sequence typing (MLST) was done by scanning the
strains’ genome assemblies against the S. aureus MLST database3,
using the mlst v2.10 program4 with default settings. Typing
of the SCCmec element was done by mapping the strains’
pseudoreads to a custom-clustered database of ccr and mec gene
complexes, plus SCCmec IV subtype-specific sequences (Kaya
et al., 2018), using the SRST2 v0.2.0 program (Inouye et al.,
2014) with the min_coverage 60 option. The validity of this
approach was investigated using pseudoreads generated from
reference sequences of SCCmec5 and by manually checking non-
typeable elements with the SCCmecFinder web-based tool (Kaya
et al., 2018). The detection of antibiotic resistance genes and
mutations and the corresponding predicted antibiotic resistance
was done with Mykrobe predictor v0.1.3, which has shown
high (>99%) sensitivity and specificity for predicting resistance
of S. aureus to a panel of 12 antibiotics (Bradley et al.,
2015).
Detection of Selected Virulence Factors
and Mobile Genetic Elements
To detect virulence factors, the full nucleotide dataset for
S. aureus available at the Virulence Factors Database (Chen
et al., 2016) was downloaded and then clustered into 265 groups
with CD-HIT, using the tools available with SRST2 with default
settings. The strains’ pseudoreads were mapped to this clustered
database using SRST2 with the min_coverage 60 option. A similar
approach was used to detect mobile genetic elements, specifically
phages and integrative conjugative elements (ICEs) that integrate
into the S. aureus chromosome. Phages were detected based on
their integrase genes, using the 12 integrase groups described
by Goerke et al. (2009) plus the integrase for φSPβ (Holden
et al., 2010). ICEs were detected based on full-length sequences,
using the seven subfamilies of ICE6013 and two subfamilies
of Tn916 (Tn916 and Tn5801) described by Sansevere and
Robinson (2017) and Sansevere et al. (2017). The validity of
this approach was investigated using pseudoreads generated
from complete sequences of reference strains of CC1, CC5,
CC8, CC30, CC151, and reference sequences of the phages and
ICEs.
3https://pubmlst.org/saureus/
4https://github.com/tseemann/mlst
5http://www.sccmec.org
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Phylogenetic Inference and
Recombination Detection
A maximum-likelihood (ML) phylogeny was constructed using
PhyML v3.0 (Guindon et al., 2009) with the HKY+G model
and five random and one BioNJ starting trees. For this analysis,
an alignment representing biallelic SNPs and invariant core
sequence present in all 598 genomes was used. Branch support
was estimated with SH-like tests. The root of the tree was
determined by first mapping reads from CC1, CC8, and ST72
outgroup sequences to the CC5 reference sequence, and then
extracting the positions of the CC5 biallelic SNPs from the
outgroups. These SNPs were then analyzed with distance-
based (BioNJ) and maximum parsimony (MP) phylogenetic
analysis. The outgroups consistently bisected a branch leading
to a strain from Argentina, which was designated as the
root. Recombination was detected using the PhyML tree with
the method implemented in ClonalFrameML (CFML; Didelot
and Wilson, 2015). Clade-specific recombination rates were
examined on the recombination-corrected ML tree using R
scripts.
Molecular Clock Analysis
The R package of Murray et al. (2016) was used to verify
that no confounding existed between the path lengths on the
recombination-corrected ML tree and the temporal distances of
the genomes, and to verify a temporal phylogenetic signal in
the positive relationship between the recombination-corrected
ML tree root-to-tip distances and year of isolation of genomes.
To estimate rates of evolution and dates of selected most recent
common ancestors (MRCAs; tree nodes), the BEAST v1.7.5
program (Drummond et al., 2012) was used. We applied an
HKY+G substitution model with empirical base frequencies, a
Bayesian Skyline demographic model with default parameters,
and both strict molecular clock and uncorrelated lognormal-
relaxed molecular clock models using flat priors between
10−3 and 10−9 substitutions/site/year as informed by other
S. aureus studies (Smyth et al., 2010). The basal strains from
Argentina were constrained as outgroups, by forcing all other
strains to be a monophyletic ingroup. Due to limitations in
computational resources, the BEAST runs used three subsamples,
each of 101 genomes. Each subsample consisted of 44 genomes
chosen to represent early isolates and major nodes on the
ML tree, plus 57 randomly selected genomes. Each subsample
was run three times, and each run was 100,000,000 steps
with sampling every 10,000 steps. Convergence and mixing
of the MCMC chains, and the effective sample sizes of
parameters (>2374 for the clock.rate parameter for every run
of the selected strict clock model), was checked using Tracer
v1.6. The first 10% of samples were removed as burn-in,
the remaining samples were combined, and maximum clade
credibility (MCC) trees were generated using LogCombiner
v1.7.5 and TreeAnnotator v1.7.5. Since rate heterogeneity among
branches was not extreme in any run of the relaxed clock model
(i.e., the 95% credibility interval for the ucld.sd and coeeffvar
parameters did not include 1.0), the strict clock model was
selected.
Ancestral State Reconstruction
The evolution of selected traits was studied using ancestral state
reconstruction under ML models. The ML analysis was done
using the ace function of the ape R package (Paradis et al.,
2004). Discrete, two-state characters were investigated including:
geography (Central and North America vs. South America),
predicted antibiotic resistance (resistant vs. susceptible), and
the presence vs. absence of virulence factors, phages, ICEs,
and predicted high-impact variants (i.e., frameshifts, start or
stop codons gained or lost). Only those traits present in 5%
(n = 30) to 95% (n = 568) of the genomes were investigated.
The recombination-corrected ML tree was used as the estimate
of the phylogeny. For each trait, both equal rates and all-
rates-different models were fit to the data, and models were
compared with a likelihood ratio test with one degree of
freedom. In no case was the simpler, equal rates model
rejected in favor of the more complicated, all-rates-different
model.
Statistical Analysis and Tree
Presentation
The basic stats package of R v3.4.2 (R Development Core Team,
2014) was used for two-sided tests of equal means (t-tests) and of
no correlation between variables (Pearson’s coefficient). Tajima’s
D, which examines the variance-normalized difference between
two estimators of genetic diversity that are sensitive to different
population dynamics, was calculated with the pegas (Paradis,
2010) R package. Tests of D = 0 were done assuming a beta
distribution of the test statistic. Trees were visualized with iTOL
(Letunic and Bork, 2016), and the ggtree (Yu et al., 2017) and
phytools (Revell, 2012) R packages.
RESULTS AND DISCUSSION
Outline of the CC5 Phylogeny
The alignment of 598 genomes of CC5 consisted of 1,081,440 bp
present in all genomes, which included 11,961 biallelic SNPs.
ML phylogenetic analysis with these sites, followed by correction
of tree branch lengths for recombination and outgroup-rooting,
resulted in the phylogeny presented in Figure 1. Several
clades were defined by consideration of their ST-SCCmec types,
geographic distribution, and statistical support. These clades are
described below.
CC5-Basal
CC5-Basal was defined as a large paraphyletic clade with a
mixture of early-branching MSSA and MRSA predominantly of
ST5-IV (SCCmec subtypes IVa, IVc, IVg, IVi) (Figure 1, light
gray shading). This clade was well-dispersed across the Western
and Eastern Hemispheres (Figure 1, ring 1). The most basal
strain in our sample was an MSSA from Argentina, and the
next most basal strains were a subclade of ST5-IVa (and one
variant of ST5) from Argentina with the pvl and sea toxin
genes that are characteristic of a recently emerged community-
associated clone (Sola et al., 2008). Despite the exclusively
South American source of these basal strains, ML ancestral state
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FIGURE 1 | Phylogeny of CC5. The ML phylogeny has recombination-corrected branch lengths and is outgroup-rooted. The major clades of CC5-Basal, CC5-I, and
CC5-II are indicated with shading. The statistical support for these clades is described in the text. The positions of reference strains are indicated with stars. The four
rings in the direction of inner-outer, show continent (ring 1), country (ring 2), SCCmec type (ring 3), and multilocus ST (ring 4) for each genome. STs with less than
three genomes were combined into “Other STs” for display purposes. Scale bar indicates number of substitutions per site.
reconstruction did not reliably identify the continent of origin
of CC5 (Supplementary Figure S1). The Bayesian phylogenetic
analysis constrained these basal strains as an outgroup, resulting
in maximal posterior probability (PP = 1) for the node, but the
ML phylogenetic analysis was unconstrained and still strongly
supported the node (SH-like support = 0.984). The Bayesian
analysis estimated the MRCA of this sample of CC5 as the late
1930s (Table 1).
CC5-Basal included the ST5-IVc USA800 clone from the
United States (McDougal et al., 2003), and the ST5-I Geraldine
clone from France (Dauwalder et al., 2008). Also included are
VRSA strains HOU1444-VR from Brazil and VRS3a from the
United States, which represented independent acquisitions of
vancomycin resistance and confirmed previous analysis (Panesso
et al., 2015). CC5-Basal further included ST5-IVa reference
strain CF-Marseille from France (Rolain et al., 2009), ST5-II
reference strain N315 from Japan (Kuroda et al., 2001), and
rare strains of ST5-I and ST5-III from Europe. The Bayesian
and ML analyses provided maximal support (PP = 1, SH-like
support = 1) for a previously described avian subclade, which
included reference strain ED98 (Lowder et al., 2009), and for a
separate subclade from porcine sources (Hau et al., 2017). The
ML analysis presented a CC5-Basal subclade that included the
porcine subclade (Figure 1, light gray shading), as a sister to the
CC5-II clade described below. However, neither the Bayesian nor
ML analyses provided statistical support for this arrangement,
so this subclade should be considered to be part of the broader
CC5-Basal clade.
CC5-I
CC5-I was defined as a large monophyletic clade with SCCmec
I (Figure 1, light red shading). This clade represented one
of three separate acquisitions of SCCmec I within CC5—
the others occurred within the CC5-Basal clade. Most early-
branching strains of CC5-I were from Europe, the rest were
from South America. The ST228-I South German clone
(Ghebremedhin et al., 2005) and related STs ST111 and
ST1481 (Budimir et al., 2010) represented these early-branching
European strains of CC5-I. The likelihood of a South American
origin among CC5-I strains in the Western Hemisphere was
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TABLE 1 | Rates of evolution and dates of CC5 clades.
Clade or subclade Date of MRCA
(95% credibility
interval)a
Ratio of recombination to
mutation events, ρ/θ (95%
credibility interval)b
All CC5 1938 (1930, 1945)
1937 (1928, 1944)
1938 (1930, 1945)
0.0046 (0.0035, 0.0059)
CC5-Basal Same as all CC5 0.0016 (0.00063, 0.0029)
CC5-I 1973 (1969, 1977)
1973 (1968, 1977)
1973 (1969, 1977)
0.0046 (0.0019, 0.0086)
. . . CC5-I expansion 1994 (1992, 1996)
1995 (1993, 1997)
1994 (1992, 1996)
0.0050 (0.0018, 0.0096)
CC5-II 1962 (1957, 1966)
1961 (1955, 1966)
1962 (1956, 1966)
0.0069 (0.0050, 0.0090)
. . . CC5-II A Same as CC5-II 0.014 (0.0095, 0.019)
. . . . . . Mexican subclade 1997 (1994, 2000)
1997 (1994, 1999)
1997 (1994, 2000)
0.019 (0.0089, 0.032)
. . . CC5-II B 1975 (1970, 1979)
1975 (1970, 1979)
1975 (1970, 1979)
0.0031 (0.0017, 0.0050)
. . . . . . CC5-II B expansion 1982 (1978, 1986)
1982 (1978, 1986)
1982 (1979, 1986)
0.0029 (0.0014, 0.0049)
aFor each clade or subclade, the three results for Date of Most Recent Common
Ancestor (MRCA) refer to the three subsamples (see the section “Materials and
Methods” for subsampling procedures). The three subsamples had estimated
mutation rates (95% credibility intervals) in units of substitutions/site/year of
1.55 × 10−6 (1.39 × 10−6, 1.71 × 10−6), 1.52 × 10−6 (1.36 × 10−6,
1.68 × 10−6), 1.55 × 10−6 (1.39 × 10−6, 1.70 × 10−6), respectively. bThe ratio
of recombination to mutation events was calculated from the complete clade or
subclade, without subsampling, using CFML.
>98% (Supplementary Figure S1). Bayesian and ML analyses
provided maximal support for CC5-I, and its MRCA was
estimated as the early 1970s (Table 1).
The terminal subclades of CC5-I represented an expansion of
the ST5-I Chilean/Cordobes clone (Sola et al., 2002) throughout
South America. The expansion node had maximal support
in Bayesian and ML analyses, and its MRCA was estimated
as the mid-1990s (Table 1). The initial branching events of
the expansion were unresolved, which was consistent with
a rapid expansion where the rate of geographic spread had
outpaced the rate of mutation. Moreover, Tajima’s D for strains
of the expansion was −2.75 (P = 3.46 × 10−5), which was
consistent with a recent expansion because it indicated an
excess of rare alleles that would be purged from an older
equilibrium population. Subsequent subclades were strongly
structured geographically by country within South America,
and included strains from Brazil, Chile and nested Argentina
strains, Peru, Argentina, Colombia, and nested Venezuela strains
(Figure 1, ring 2).
CC5-II
CC5-II was defined as a very large monophyletic clade with
SCCmec II (Figure 1, light blue shading). This clade represented
one of two separate acquisitions of SCCmec II within CC5—
the other occurred within the CC5-Basal clade on the branch
leading to reference strain N315. CC5-II was subdivided into
a paraphyletic early-branching subclade, CC5-II A, and a
monophyletic terminal subclade, CC5-II B. In the Western
Hemisphere, CC5-II strains were mostly from Central and North
America, but some strains were from Brazil, Ecuador, and
Venezuela. The likelihood of a Central or North American origin
among CC5-II strains in the Western Hemisphere was >99%
(Supplementary Figure S1). This clade had maximal support
in Bayesian and ML analyses, and subclade CC5-II B had near
maximal support (PP = 1, SH-like support = 0.997). The MRCAs
of CC5-II and CC5-II B, respectively, were estimated as the early
1960s and mid-1970s (Table 1).
Of the four sampled reference strains of the ST5-II USA100
clone from the United States, one was within CC5-II A and
three were within CC5-II B (Figure 1), which indicated that this
clone was polyphyletic. Furthermore, the separation of ST5-II
strains from New York in the United States and from Japan into
distinct clades (CC5-II B and CC5-Basal, respectively), indicated
that the New York/Japan clone was polyphyletic; in other words,
there are separate New York and Japan clones, and not a single
New York/Japan clone. Our study focused sampling on the
Western Hemisphere, but it will be interesting to see if future
studies place Asian SCCmec II-positive CC5 strains with strain
N315 in CC5-Basal or with the diverse strains in CC5-II. Lastly,
of the 11 sampled ST5-II VRSA strains from the United States,
five were within CC5-II A and six were within CC5-II B
(Figure 1, brown stars). Our analysis supported a previous
analysis that indicated independent acquisitions of vancomycin
resistance for most strains (Kos et al., 2012), but our analysis also
highlighted the close relationships of strain pairs VRS1/VRS6,
VRS5/VRS7, VRS9/VRS10, and VRS11a/VRS11b. Importantly,
no evidence of further dissemination of these VRSA strains was
obtained, as ML models of ancestral state reconstruction did
not identify strains other than the known VRSAs to descend
from vancomycin-resistant MRCAs (nodes). In the absence of
vancomycin, the slight fitness burden reported for carriage of the
vanA operon (Foucault et al., 2009) may be sufficient to impede
the dissemination of these strains.
A major feature of CC5-II A was a divergent subclade that
included all of the sampled strains from Mexico (Figure 1). Early-
branching strains of this subclade were from the United States.
This subclade had near maximal support (PP = 1, SH-like
support = 0.999) in Bayesian and ML analyses, and its MRCA was
estimated as the late 1990s (Table 1). This time period coincided
with the replacement of CC30-MRSA in Mexico by CC5-MRSA,
as previously described (Aires De Sousa et al., 2001; Velazquez-
Meza et al., 2004; Echaniz-Aviles et al., 2006). This subclade
was further subdivided into ST5-II and ST1011-II subclades that
showed geographic structure by region within Mexico: ST5-II
was from Central and Western Mexico, and ST1011-II was from
Central and Northern Mexico.
The ST225-II Rhine-Hesse clone from Central Europe
(Schulte et al., 2013) was an early offshoot of CC5-II B. The ST5-II
reference strain JH1 from the United States (Mwangi et al., 2007)
also nested within CC5-II B. The terminal subclades of CC5-II B
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represented an expansion of ST5-II, and subsequent proliferation
of unnamed clones such as ST105-II, ST125-II, ST231-II, and
ST496-II (Figure 1, ring 3), in Central and North America.
The expansion node had maximal support in Bayesian and ML
analyses, and dated to the early 1980s (Table 1). Several of the
initial branching events of the expansion were unresolved, which
was consistent with a rapid expansion. Also, Tajima’s D was−2.81
(P = 5.91× 10−6), which was consistent with a recent expansion.
CC5-II B showed some geographic structure at the country level,
such as a subclade with 18 of 21 strains from Guatemala, two
subclades with 10–11 strains each from Canada, and a subclade
with 18 strains from California in the United States (Figure 1,
ring 2).
Relatively Low Recombination Rates
in CC5
Our estimate of the ratio of recombination to mutation events
in this sample of CC5 (0.0046) (Table 1) was several orders
of magnitude lower than previously estimated for CC5 (1.08)
(Murray et al., 2017). However, the previous estimate detected
a large proportion of recombination events in poultry strains
and our sample included only six poultry strains for which no
recombination events were detected. Sampling differences and
the use of different recombination detection methods might
explain the discrepancy between our recombination estimate and
that of Murray et al. (2017). Our recombination estimate for
CC5 was also lower than previously reported for the non-CC5
clones of ST239-III (Castillo-Ramirez et al., 2012) and ST8-IV
USA300 (Challagundla et al., 2018); ranges of 0.05–0.29 and
0.12–0.29, respectively. The relatively low recombination rate
estimated here using CFML was confirmed with an independent
analysis using Gubbins (Croucher et al., 2015): 58 recombination
events were detected by CFML and 29 were detected by Gubbins.
In our sample, CC5-II A had a significantly higher ratio of
recombination to mutation events compared to other CC5 clades
(Table 1). This result was driven by a relatively large number of
recombination events in the Mexican subclade. Thus, our analysis
did not support the hypothesis that CC5 was generally more
promiscuous than other S. aureus genetic backgrounds. Other
explanations for why VRSA strains have repeatedly appeared in
CC5 should be sought, such as whether CC5 has a unique gene
regulatory environment that favors vanA expression or a unique
ecological niche that favors interactions with Enterococcus spp.
Evidence for an Antibiotic
Resistance-Toxicity Tradeoff in CC5
The full range of detected mutations and genes associated with
antibiotic resistance, and selected virulence factors and mobile
genetic elements, is provided in Supplementary Table S1. Our
discussion is focused on those traits that are variably distributed
among CC5 clades in the Western Hemisphere. Besides the high
prevalence of resistance to β-lactams in all clades, CC5-I and
CC5-II had a high prevalence of resistance to fluoroquinolones,
macrolides, and lincosamides, and CC5-I also had a high
prevalence of resistance to aminoglycosides (Table 2). The
most common resistance mechanism to fluoroquinolones was
the “double-serine mutations,” Ser84Leu in gyrA and Ser80Phe
in grlA, that have been noted to occur in other successful
MRSA clones (Fuzi et al., 2017). These double-serine mutations
accounted for fluoroquinolone resistance in 141 of 147 (96%)
resistant strains of CC5-I, and 107 of 239 (45%) resistant
strains of CC5-II. Of note, CC5-II B had a lower prevalence of
fluoroquinolone resistance compared to CC5-II A (58% vs. 98%,
respectively) (Table 2), and the main mechanism of resistance in
CC5-II B was the single mutation in gyrA that accounted for 117
of 141 (83%) resistant strains of CC5-II B. The most common
resistance mechanism to macrolides and lincosamides was the
ermA gene: alone accounting for 139 of 144 (97%) resistant
strains of CC5-I, and 268 of 342 (78%) resistant strains of CC5-II.
The ermA gene is known to be carried on Tn554 on the SCCmec II
element (Kuroda et al., 2001), and it occurred on Tn554 elsewhere
in the chromosome of the examined strains with SCCmec I
elements. Aminoglycoside resistance, which occurred mostly in
CC5-I, was exclusively attributed to the aacA–aphD bifunctional
gene in our sample, and this gene occurred on composite
transposon Tn4001 in examined strains. Mobile genetic elements
also carried some rare antibiotic resistance genes. For example,
ICE element (also known as conjugative transposon) Tn916
accounted for all eight strains with tetM-mediated tetracycline
resistance. The other family of ICE elements known in S. aureus,
ICE6013, was not observed to carry any antibiotic resistance
genes and was common among the avian subclade of CC5-Basal
(Table 2).
Common virulence factors of CC5 included the sak, scn, and
chp genes of the immune evasion gene cluster (IEC) present on
phage φSa3, and seg, sei, sem, sen, seo, andψent of the enterotoxin
gene cluster (EGC) as well as lukDE present on genomic island
νSaβ (Table 2). CC5-Basal appeared to have a more diverse array
of toxins, and the pvl (lukFS), sec, sel, and etb toxins occurred
solely in this clade. CC5-I was unique in having a low prevalence
of the fnbB adhesin gene; it was present in only 3% of CC5-
I strains, and in >96% of strains of other clades (Table 2).
On the other hand, the plasmid-borne sed, sej, ser toxins were
most common in CC5-II B strains. Phages also showed some
differences in CC5 clade distribution: phages φSa2 and φSa7
were most common in CC5-I strains, and phage φSa1 was most
common in CC5-II B strains (Table 2).
We tested the hypothesis that antibiotic resistances and toxins
were randomly distributed throughout CC5 and across time
by comparing the average number of antibiotic resistances and
toxins per genome in the various clades and by examining these
traits with distance from the root of the CC5 tree. CC5-Basal
had significantly fewer antibiotic resistances and more toxins
than the other clades (Table 3). CC5-I had the opposite pattern,
significantly more antibiotic resistances and fewer toxins than
the other clades. CC5-II also had significantly more antibiotic
resistances, but it had more toxins due to greater toxin acquisition
in CC5-II B (e.g., sed, sej, ser) that offset the loss in CC5-II
A (Table 3). Overall, the number of antibiotic resistances per
genome increased with distance from root, and the number of
toxins per genome decreased with distance from root (Table 3).
A similar trend of increased number of antibiotic resistances
with distance from root has been reported previously for CC8
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TABLE 2 | Prevalence of selected traits in CC5 clades.
Trait Clade or subcladea
CC5-Basal (n = 107) CC5-I (n = 148) CC5-II A (n = 100) CC5-II B (n = 243)
Antibiotic resistances CIP 33 (30.84) 147 (99.32) 98 (98) 141 (58.02)
ERY 28 (26.17) 144 (97.3) 99 (99) 243 (100)
CLIN 15 (14.02) 144 (97.3) 99 (99) 243 (100)
FUS 1 (0.93) 1 (0.68) 0 (0) 3 (1.23)
GENT 16 (14.95) 143 (96.62) 19 (19) 13 (5.35)
OXA 63 (58.88) 148 (100) 99 (99) 239 (98.35)
MUP 1 (0.93) 1 (0.68) 6 (6) 10 (4.12)
PEN 89 (83.18) 148 (100) 100 (100) 241 (99.18)
RIF 8 (7.48) 11 (7.43) 7 (7) 10 (4.12)
TET 20 (18.69) 1 (0.68) 1 (1) 4 (1.65)
TMP 10 (9.35) 1 (0.68) 16 (16) 12 (4.94)
VANC 2 (1.87) 0 (0) 5 (5) 6 (2.47)
Virulence factors etb 9 (8.41) 0 (0) 0 (0) 0 (0)
lukDE 104 (97.2) 145 (97.97) 89 (89) 229 (94.24)
lukFS 6 (5.61) 0 (0) 0 (0) 0 (0)
sea 45 (42.06) 16 (10.81) 38 (38) 3 (1.23)
seb 7 (6.54) 0 (0) 0 (0) 6 (2.47)
sec 4 (3.74) 0 (0) 0 (0) 0 (0)
sed 20 (18.69) 0 (0) 24 (24) 163 (67.08)
seg 106 (99.07) 142 (95.95) 90 (90) 226 (93)
sei 106 (99.07) 144 (97.3) 87 (87) 226 (93)
sej 23 (21.5) 0 (0) 23 (23) 163 (67.08)
sek 2 (1.87) 1 (0.68) 0 (0) 1 (0.41)
sel 4 (3.74) 0 (0) 0 (0) 0 (0)
sem 107 (100) 144 (97.3) 91 (91) 231 (95.06)
sen 106 (99.07) 139 (93.92) 89 (89) 225 (92.59)
seo 107 (100) 146 (98.65) 91 (91) 231 (95.06)
sep 58 (54.21) 7 (4.73) 63 (63) 12 (4.94)
seq 2 (1.87) 0 (0) 0 (0) 1 (0.41)
ser 22 (20.56) 1 (0.68) 23 (23) 163 (67.08)
sev 107 (100) 144 (97.3) 87 (87) 228 (93.83)
tst1 12 (11.21) 1 (0.68) 1 (1) 1 (0.41)
ψent2 106 (99.07) 143 (96.62) 90 (90) 228 (93.83)
fnbB 105 (98.13) 5 (3.38) 97 (97) 238 (97.94)
sdrE 99 (92.52) 143 (96.62) 89 (89) 229 (94.24)
chp 70 (65.42) 118 (79.73) 85 (85) 223 (91.77)
scn 85 (79.44) 133 (89.86) 91 (91) 226 (93)
sak 86 (80.37) 133 (89.86) 92 (92) 230 (94.65)
Phages φSa12int 1 (0.93) 0 (0) 0 (0) 2 (0.82)
φSa1int 39 (36.45) 3 (2.03) 41 (41) 194 (79.84)
φSa2int 31 (28.97) 110 (74.32) 61 (61) 132 (54.32)
φSa3int 92 (85.98) 134 (90.54) 90 (90) 231 (95.06)
φSa4int 10 (9.35) 2 (1.35) 16 (16) 13 (5.35)
φSa5int 6 (5.61) 2 (1.35) 6 (6) 66 (27.16)
φSa6int 14 (13.08) 6 (4.05) 40 (40) 20 (8.23)
φSa7int 18 (16.82) 147 (99.32) 65 (65) 75 (30.86)
φSa9int 0 (0) 0 (0) 1 (1) 0 (0)
φSPβint 0 (0) 0 (0) 0 (0) 3 (1.23)
ICEs ICE6013_sf1 23 (21.49) 1 (0.68) 6 (6) 6 (2.47)
ICE6013_sf5 8 (7.48) 0 (0) 0 (0) 0 (0)
ICE6013_sf6 6 (5.61) 0 (0) 0 (0) 0 (0)
Tn916 6 (5.61) 0 (0) 0 (0) 2 (0.82)
aNumbers in cells refer to the number (percentage) of genomes in the indicated clade or subclade that have the indicated trait.
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TABLE 3 | Comparisons of antibiotic resistance and toxin traits in CC5 clades.
Clade or subclade Number of genomes Average Correlation between number per
number per genome (SD)a genome and root-to-tip distanceb
Antibiotic resistancesc Toxinsd Antibiotic resistancesc Toxinsd
All CC5 598 4.8 (1.6) 9.2 (2.1) 0.394∗∗∗∗ −0.326∗∗∗∗
CC5-Basal 107 2.7 (2.0)∗∗∗∗ 9.9 (2.1)∗∗∗∗ 0.029 −0.295∗∗
CC5-I 148 6.0 (0.6)∗∗∗∗ 7.9 (1.0)∗∗∗∗ −0.178∗ 0.126
CC5-II 343 5.0 (0.9)∗∗ 9.4 (2.3)∗∗∗ −0.017 −0.194∗∗∗
. . . CC5-II A 100 5.5 (1.0)∗∗∗∗ 8.9 (2.4) −0.224∗ −0.037
. . . CC5-II B 243 4.8 (0.8) 9.7 (2.2)∗∗∗∗ −0.089 −0.284∗∗∗∗
aStandard deviation (SD), test is for equal means of clade or subclade vs. all others. bTest is for zero correlation, root-to-tip distance is from CFML tree. cFrom a possible
total of 12 predicted resistances (CIP, CLIN, ERY, FUS, GENT, OXA, MUP, PEN, RIF, TET, TMP, VANC). dFrom a possible total of 20 toxins (etb, lukDE, lukFS, sea, seb,
sec, sed, seg, sei, sej, sek, sel, sem, sen, seo, sep, seq, ser, sev, tst1). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.
(Strommenger et al., 2014). While these results highlight the
importance of antibiotic resistance to the evolution of CC5, they
are subject to a statistical caveat. Not all of the data points are
independent because mobile genetic elements can carry multiple
linked antibiotic resistance or toxin genes and affect multiple
traits in a single evolutionary event; for example, ermA mediates
both macrolide and lincosamide resistance, and the EGC encodes
multiple enterotoxins.
Convergent Genomic Changes
Associated With Expansions of CC5
The evolution of selected traits was studied in more detail under
an ML model of ancestral state reconstruction. A major finding of
this analysis was that resistance to fluoroquinolones, macrolides,
and lincosamides was gained, and the sep toxin gene was lost,
independently, along the phylogenetic backbone leading to the
expansion nodes of CC5-I and CC5-II B (Figure 2, pie-charts).
The likelihood of the nodes that precede CC5-I and CC5-II
B having these resistances was <5–6% for fluoroquinolones
and <1% for macrolides and lincosamides, and >98% for the
presence of sep. By the time of the expansion nodes of CC5-
I and CC5-II B, the likelihood of having all three resistances
was >99%, and <1% for the presence of sep (Figure 2, pie-
charts).
The independent evolution of the same traits from different
starting points on the CC5 phylogeny (i.e., convergence), and
the close timing of their evolution with independent expansions,
suggests a causal relationship. Use of β-lactams, macrolides,
and fluoroquinolones rank highly among antibiotics in the
United States, Canada, and Brazil (Center for Disease Dynamics
et al., 2015), and likely other countries in South America. Thus,
the gain of these resistances may reflect a common selective
pressure in the Western Hemisphere. As can be seen in Figure 2
(bar charts), some of the strains that appeared after the expansion
of CC5-II B have subsequently lost fluoroquinolone resistance.
As indicated above, many of the CC5-II B strains that retained
fluoroquinolone resistance have retained the gyrA resistance
allele but have lost the grlA resistance allele. Fluoroquinolone
resistance mutations and especially the grlA mutation, have been
shown to negatively impact the fitness of S. aureus strains in the
absence of antibiotic (Horváth et al., 2012; Knight et al., 2012).
However, these fitness effects may be mitigated in the presence
of sub-inhibitory levels of the antibiotic (Gustave et al., 2018).
These observations suggest that fluoroquinolone resistance may
have an important role in the initial phase of epidemic spread
CC5-MRSA clones, but less of a role in the subsequent phase
of endemic residence in hospitals. Alternatively, there may have
been efforts to reduce fluoroquinolone use in recent years, which
in turn may have alleviated the selective pressure for clones to
remain resistant. The CC5-II B expansion began approximately
one decade earlier than the CC5-I expansion (Table 1), so it
will be interesting to see if CC5-I begins to lose fluoroquinolone
resistance and the grlA resistance allele over time as has happened
in CC5-II B.
The association of the CC5-I and CC5-II B expansions with
independent losses of the sep toxin gene was unexpected. This
gene is present on the IEC of phage φSa3. Its loss preceding
the CC5-I and CC5-II B expansions does not represent loss
of the phage, since the majority of strains retained the phage
and other virulence factors of the IEC such as sak, scn, and
chp (Table 2). The completely sequenced reference strains
N315 and JH1, respectively, provide full sequences of the IEC
before and after loss of sep. A 1.75 kb region of the IEC
that includes the sep gene was noted to be variably present in
S. aureus by van Wamel et al. (2006). To our knowledge, the
mechanism of sep excision from the IEC is unknown, and the
function of sep is unstudied beyond its characterization as a
superantigen with emetic activity (Omoe et al., 2005, 2013). In
one study, the presence of sep was identified as the only S. aureus
virulence factor among 30 tested, to associate with bacteremia
in hospitalized MRSA carriers (Calderwood et al., 2014). While
sep and other genome variations might influence the risk of
bacteremia, those types of invasive infections are dead-ends for
MRSA transmission.
The overall trend of decreased number of toxins per genome
with distance from root, and parallel losses of sep in particular,
suggests that the CC5 expansions occurred with strains that
were less virulent than their precursors. Additional observations
that support this notion come from an analysis of 35 high-
frequency, high-impact mutations (listed in Supplementary
Table S1). A total of 14 of these mutations occurred in CC5-
I by the time of the expansion and three more occurred after
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FIGURE 2 | Convergent evolution within CC5. The ML phylogeny of Figure 1 is shown. The major clades, multilocus ST, and SCCmec type are shown for reference
purposes and colored as in Figure 1. The CC5-I and CC5-II B expansion nodes are indicated with arrows. ML ancestral state reconstruction is shown along the
phylogenetic backbone leading to the two expansion nodes; the four pie-charts at each of the backbone nodes indicate the likelihood of (in left-to-right order),
fluoroquinolone, macrolide, and lincosamide resistance (red) or susceptibility (blue), and the presence (red) or absence (blue) of the sep toxin gene. Table adjacent to
the tree indicates these traits in each genome. Scale bar indicates number of substitutions per site.
the expansion. One of these was a frameshift mutation in the
sasG adhesin gene, which also occurred in CC5-I strains that
lacked the fnbB gene. Loss of sasG and fnbB function would
be expected to result in reduced virulence especially in biofilm-
associated infections (Vergara-Irigaray et al., 2009; Geoghegan
et al., 2010). In CC5-II B, only two high-frequency, high-
impact mutations occurred by the time of the expansion, but
four occurred afterward. One of these mutations resulted in
the loss of the stop codon of the srtA sortase gene, which
is a virulence factor that attaches surface proteins with the
LPXTG motif to S. aureus’ peptidoglycan cell wall. Loss of
sortases function would be expected to result in reduced
virulence (Mazmanian et al., 2000). One interesting gain-
of-function change in CC5-II B was a frameshift mutation
that restored the start codon of the toxin component of the
axe1/txe1 toxin/antitoxin system. Expression of this system in
CC8 strain Newman is increased after exposure to subinhibitory
concentrations of erythromycin and tetracycline (Donegan and
Cheung, 2009), but it has not been studied in CC5 to our
knowledge.
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CONCLUDING REMARKS
CC5-MRSA in the Western Hemisphere are highly diverse, even
those strains that share the same ST-SCCmec type and circulate
in the same country. More precise definitions for commonly
sampled clones such as the USA100 and New York/Japan
clones, and likely other clones such as USA800, are needed
because different strains with those labels may have shared
a MRCA > 50 years ago and may have divergent genomes.
Our study provides the first systematic effort at organizing
this diversity from a phylogenomic perspective and it provides
a robust landmark for future genome studies of CC5-MRSA
strains. The geographic structure of CC5 that is evident at the
continent, country, and even region levels in some cases, suggests
that a more precise delineation of the patterns of geographic
spread of CC5-MRSA clones may be possible. MRSA clones of
clinical relevance branch at nearly all time depths in the CC5
phylogeny; from the earliest-branching ST5-IV clones within the
CC5-Basal clade that are an emerging problem in hospitals and
communities in South America, to the latest-branching ST5-II
clones within the CC5-II B clade that are a continuing problem
in hospitals in Central and North America. Our analysis shows
relatively low rates of recombination in CC5, which indicates that
the propensity of CC5 to acquire vanA-mediated vancomycin
resistance is not likely due to enhanced promiscuity and prompts
study of other potential mechanisms. In tracing the evolution of
selected traits of CC5, we discovered that some of the genomic
changes that occurred prior to expansions of the CC5-I and CC5-
II B clades represented instances of convergent evolution. While
the convergent acquisition of resistance to widely prescribed
antibiotics is a recurring theme in the history of successful MRSA
clones, the convergent loss of the sep toxin and the trend of
decreasing number of toxins with distance from the CC5 tree
root and loss of other virulence factors is a unique finding. Taken
together, our results suggest that more antibiotic-resistant and
less virulent CC5-MRSA clones may be better able to spread
geographically.
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